4/24
01:32 pm
dmac
Rating for DMAC
Low
Report
Rating for DMAC
4/24
01:32 pm
dmac
Rating for DMAC
Low
Report
Rating for DMAC
4/24
10:27 am
dmac
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $8.00 price target on the stock.
Low
Report
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $8.00 price target on the stock.
4/24
10:27 am
dmac
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $8.00 price target on the stock.
Low
Report
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $8.00 price target on the stock.
3/21
02:30 pm
dmac
Rating for DMAC
Low
Report
Rating for DMAC
3/21
02:30 pm
dmac
Rating for DMAC
Low
Report
Rating for DMAC
3/21
09:37 am
dmac
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $6.00 price target on the stock, down previously from $7.00.
Medium
Report
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $6.00 price target on the stock, down previously from $7.00.
3/21
08:41 am
dmac
Rating for DMAC
Medium
Report
Rating for DMAC
3/21
08:41 am
dmac
Rating for DMAC
Medium
Report
Rating for DMAC